Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| ID | DOID:0080799 |
| Name | sinonasal undifferentiated carcinoma |
| Definition | A nasal cavity carcinoma that arises from the sinonasal tract and that is characterized by the presence of small to medium size malignant cells. |
| Source | DiseaseOntology.org |
| Alt Ids | |
| Path | disease disease of cellular proliferation cancer organ system cancer respiratory system cancer nasal cavity cancer nasal cavity carcinoma sinonasal undifferentiated carcinoma |
| Molecular Profile | Therapy | Indication/Tumor Type | Response Type | Profile Response Detail |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05053737 | Phase Ib/II | Atezolizumab | Radiotherapy in Combination With Atezolizumab Prior to Surgical Resection for HPV Unrelated HNSCC | Completed | USA | 0 |
| NCT05879484 | Phase Ib/II | DS-3201b + Pembrolizumab | Study of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERAS | Withdrawn | USA | 0 |
| NCT05925491 | Phase II | Cisplatin + Docetaxel + Pembrolizumab | Pembrolizumab in Locally Advanced Sinonasal Carcinoma (NeoPeSino) | Recruiting | ITA | 0 |
| NCT06176989 | Phase II | Enasidenib | Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors | Recruiting | USA | 0 |
| NCT06868433 | Phase I | Pembrolizumab + TMV vaccine TMV vaccine | TMV Vaccine Therapy Alone and with Pembrolizumab for the Treatment of Recurrent And/or Metastatic Head and Neck Squamous Cell Cancer | Recruiting | USA | 0 |
| NCT06940180 | Phase II | Carboplatin + Docetaxel + Toripalimab-tpzi Toripalimab-tpzi Cisplatin | Toripalimab With Chemotherapy for Sinus Cancer | Recruiting | USA | 0 |